Beyond the Pill: Unlocking the Power of Liquid Suspensions
About This Webcast
As drug developers seek out novel solutions for geriatric and pediatric populations and patients with difficulty swallowing (dysphagia), liquid suspensions have become increasingly popular. However, while liquid suspensions have distinct advantages to pills, tablets, and traditional liquid solutions for specific patient populations, their unique formulation requirements make them highly challenging to develop and manufacture. In order to meet rising demand, CDMO partners must have the necessary expertise to accelerate liquid suspension formulation development. In this webinar, Mikart’s very own Gus LaBella, Director of Formulation Development, shares the keys to liquid suspension formulation, including: Understanding the unique characteristics of liquid suspensions Leveraging novel ion exchange technology Having experience with difficult-to-formulate liquid solutions Maintaining dedicated development, manufacturing, and production facilities
Speakers
Gus LaBella
Director of Formulation Development , Mikart, LLC
Gus LaBella, director of formulation development at Mikart, has over 30 years of experience in oral dosage form development. He is responsible for the management of the formulation development team and the development, transfer, and scale-up of new products. Gus’ role also provides support in Mikart’s manufacturing area regarding troubleshooting and process improvements of currently manufactured products. Prior to joining Mikart, Gus worked as a formulation technologies manager at Colorcon®, a pharmaceutical excipients manufacturer. Gus’ experience also includes various positions within the research and development group at McNeil Consumer Products, a Johnson & Johnson company. While at McNeil, Gus held positions in product development, investigational supplies, support to marketed products, and R&D technologies. His skills range from pre-formulation of novel dosage forms to post-launch support of marketed products. His areas of interest are wet granulation and design of experiments. Gus holds a B.S. in materials engineering from Drexel University in Philadelphia, Pennsylvania.
Tim Wright
Editor-in-Chief , Contract Pharma
Tim Wright is the editor of Contract Pharma magazine, which is a trade publication serving thousands of pharma and biopharma outsourcing professionals. He has been editor at Rodman Media since 2006. Prior to his position at Contract Pharma, he was an editor at Coatings World and Nonwovens Industry publications. Tim has a B.A. from Montclair State University in New Jersey where he studied English literature and journalism.